West Pharmaceutical Services, Inc. (WST) Stock
WST Key Statistics
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
CEO: Michel Lagarde. Company website
WST — Frequently Asked Questions
What is the WST stock price today?
West Pharmaceutical Services, Inc. (WST) trades at $362.16, down 1.21% on the day, as of Sep 20, 2026 14:59 UTC.
What is West Pharmaceutical Services, Inc.'s market cap?
West Pharmaceutical Services, Inc. has a market capitalisation of $25.49B, calculated from the live WST share price and shares outstanding.
What is the P/E ratio of WST?
WST trades at a trailing P/E of 46.31, from earnings per share of $7.82 over the last twelve months.
How much revenue does West Pharmaceutical Services, Inc. make?
West Pharmaceutical Services, Inc. generated revenue of $3.33B over the trailing twelve months, which puts the stock at 7.66 times sales.
What is the 52-week range for WST?
WST has traded between $223.83 and $386.00 over the past 52 weeks, and the last price is 6.2% below that high.
Is West Pharmaceutical Services, Inc. profitable?
Yes. West Pharmaceutical Services, Inc. keeps 16.98% of revenue as net income over the trailing twelve months.
What is the analyst price target for WST?
Wall Street analysts rate WST Buy, with an average price target of $407.00, 12.4% above the current price.
What sector is West Pharmaceutical Services, Inc. in?
West Pharmaceutical Services, Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
Who is the CEO of West Pharmaceutical Services, Inc.?
Michel Lagarde is the chief executive of West Pharmaceutical Services, Inc., which employs 10,800 people.
Where can I track WST in real time?
QFI Terminal shows WST with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See WST live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open WST in Terminal See plans